Skip to main content
Premium Trial:

Request an Annual Quote

OHSU's Microarray Core Facility Licenses GeneGo's Software Suite

NEW YORK (GenomeWeb News) — Oregon Health and Science University has licensed several of GeneGo’s data analysis software platforms for use in its Affymetrix Microarray Core facility, GeneGo said today.
 
Under the agreement, the OHSU microarray facility will use GeneGo’s MetaCore for pathways analysis, its MapEditor for pathway editing and communications, and its MetaLink for adding interactions to MetaCore-curated pathways.
 
The microarray facility provides RNA expression profiling and DNA variation analysis services using Affy’s GeneChip oligonucleotide arrays.
 
Financial terms of the agreement were not released.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.